Legend Biotech Corp Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019
Legend Biotech Corp (LEGN) reported Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 of $4.52 per share for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 · last filed 2026-03-10
| Period end | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2025-12-31 | $4.52 20-F · filed 2026-03-10 |
| 2024-12-31 | $6.27 20-F · filed 2026-03-10 |
| 2023-12-31 | $5.07 20-F · filed 2026-03-10 |
| 2022-12-31 | $1.80 20-F · filed 2025-03-11 |
| 2021-12-31 | $1.33 20-F · filed 2024-03-19 |
| 2020-12-31 | $1.01 20-F · filed 2023-03-30 |